Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Morton

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Journal of Drugs in Dermatology : JDD|September 20, 2005
Immunotherapy today: the story of a vaccineDonald L Morton
Annals of Surgical Oncology|March 17, 2004
Sentinel node mapping and an International Sentinel Node Society: current issues and future directionsDonald L Morton
Journal of Surgical Oncology|September 20, 2007
In honor of Alfred Schutt Ketcham, M.DDonald L Morton
Clinical & Experimental Metastasis|June 26, 2012
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanomaDonald L Morton
Advances in Surgery|November 2, 2007
The role of sentinel lymph node biopsy in the management of melanomaFarin Amersi, Donald L Morton
Archives of Dermatology|May 21, 2008
Sentinel node biopsy: facts to clear the alleged cloudsDonald L Morton, Robert Elashoff
The American Journal of Surgical Pathology|March 16, 2006
Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodesAlistair J Cochran, Donald L Morton
Seminars in Cancer Biology|March 6, 2004
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccineEddy C Hsueh, Donald L Morton
Advances in Surgery|September 5, 2003
Melanoma: is immunotherapy of benefit?Mark B Faries, Donald L Morton
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 1, 2005
Therapeutic vaccines for melanoma: current statusMark B Faries, Donald L Morton
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Journal of Drugs in Dermatology : JDD|September 20, 2005
Immunotherapy today: the story of a vaccineDonald L Morton
Annals of Surgical Oncology|March 17, 2004
Sentinel node mapping and an International Sentinel Node Society: current issues and future directionsDonald L Morton
Journal of Surgical Oncology|September 20, 2007
In honor of Alfred Schutt Ketcham, M.DDonald L Morton
Clinical & Experimental Metastasis|June 26, 2012
Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanomaDonald L Morton
Advances in Surgery|November 2, 2007
The role of sentinel lymph node biopsy in the management of melanomaFarin Amersi, Donald L Morton
Archives of Dermatology|May 21, 2008
Sentinel node biopsy: facts to clear the alleged cloudsDonald L Morton, Robert Elashoff
The American Journal of Surgical Pathology|March 16, 2006
Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodesAlistair J Cochran, Donald L Morton
Seminars in Cancer Biology|March 6, 2004
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccineEddy C Hsueh, Donald L Morton
Advances in Surgery|September 5, 2003
Melanoma: is immunotherapy of benefit?Mark B Faries, Donald L Morton
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 1, 2005
Therapeutic vaccines for melanoma: current statusMark B Faries, Donald L Morton
Pageof 15